Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jinyuan Chen, Ziyun Yuan, Yifan Tu, Wanyu Hu, Cong Xie & Ling Ye. (2023) Experimental and computational models to investigate intestinal drug permeability and metabolism. Xenobiotica 53:1, pages 25-45.
Read now
Read now
Suresh Palle & Prasad Neerati. (2018) Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats. Xenobiotica 48:10, pages 1028-1036.
Read now
Read now
Ana Costa, Bruno Sarmento & Vítor Seabra. (2014) An evaluation of the latest in vitro tools for drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 103-119.
Read now
Read now
Hiroshi Komura & Masahiro Iwaki. (2011) In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. Drug Metabolism Reviews 43:4, pages 476-498.
Read now
Read now
V. Tzankova, C. Ivanova, S. Dragoni, N. Danchev & M. Valoti. (2011) Precision-Cut Slices as a Tool for Studying Phase II Drug Metabolism in Rat Small Intestine in Vitro. Biotechnology & Biotechnological Equipment 25:1, pages 2279-2283.
Read now
Read now
A. Bruyère, X. Declèves, F. Bouzom, L. Proust, M. Martinet, B. Walther & Y. Parmentier. (2009) Development of an optimized procedure for the preparation of rat intestinal microsomes: comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains. Xenobiotica 39:1, pages 22-32.
Read now
Read now
D. Projean, E. Lessard, M. P. Ducharme & J. Ducharme. (2007) Use of Freund's Complete Adjuvant (FCA) in inflammatory pain models: Consequences on the metabolism and pharmacokinetics of the non-peptidic delta receptor agonist SNC80 in the rat. Xenobiotica 37:8, pages 870-883.
Read now
Read now
P. H. Roos, S. Tschirbs, A. Hack, P. Welge & M. Wilhelm. (2004) Different mechanisms of handling ingested polycyclic aromatic hydrocarbons in mammalian species: organ-specific response patterns of CYP1A1-induction after oral intake of PAH-contaminated soils. Xenobiotica 34:9, pages 781-795.
Read now
Read now
R. De Kanter, M. Monshouwer, A. L. Draaisma, M. H. De Jager, I. A. M. De Graaf, J. H. Proost, D. K. F. Meijer & G. M. M. Groothuis. (2004) Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica 34:3, pages 229-241.
Read now
Read now
Articles from other publishers (22)
Li Li, Dinh Bui, Wei Zhu & Eun‐Jung (Zenobia) Jeong. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
801
818
.
Jiaxin Zhang, Qiushi Xie, Weimin Kong, Zhongjian Wang, Shuting Wang, Kaijing Zhao, Yang Chen, Xiaodong Liu & Li Liu. (2020) Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats. Journal of Pharmacy and Pharmacology 72:3, pages 448-460.
Crossref
Crossref
Yasuhiro Uno, Shotaro Uehara, Takashi Inoue, Shu Kawamura, Norie Murayama, Miyu Nishikawa, Shinichi Ikushiro, Erika Sasaki & Hiroshi Yamazaki. (2020) Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets. Biochemical Pharmacology 172, pages 113748.
Crossref
Crossref
Zhongjian Wang, Hanyu Yang, Jiong Xu, Kaijing Zhao, Yang Chen, Limin Liang, Ping Li, Nan Chen, Donghao Geng, Xiangping Zhang, Xiaodong Liu & Li Liu. (2019) Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters. Drug Metabolism and Disposition 47:10, pages 1066-1079.
Crossref
Crossref
Yasuhiro Uno, Rika Takahira, Norie Murayama, Shunsuke Onozeki, Shu Kawamura, Shotaro Uehara, Yoshinori Ikenaka, Mayumi Ishizuka, Shinichi Ikushiro & Hiroshi Yamazaki. (2019) Functional and molecular characterization of UDP-glucuronosyltransferase 2 family in cynomolgus macaques. Biochemical Pharmacology 163, pages 335-344.
Crossref
Crossref
Yasuhiro Uno, Rika Takahira, Norie Murayama, Yu Ishii, Yoshinori Ikenaka, Mayumi Ishizuka, Hiroshi Yamazaki & Shinichi Ikushiro. (2018) Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques. Biochemical Pharmacology 155, pages 172-181.
Crossref
Crossref
Oliver J.D. Hatley, Christopher R. Jones, Aleksandra Galetin & Amin Rostami‐Hodjegan. (2017) Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors. Biopharmaceutics & Drug Disposition 38:3, pages 187-208.
Crossref
Crossref
Sunday O. Nduka, Mathew J. Okonta, Daniel L. Ajaghaku, Kosisochi C. Amorha & Chinwe V. Ukwe. (2017) Inhibition of cytochrome P450 3A enzyme by Millettia aboensis : its effect on the pharmacokinetic properties of efavirenz and nevirapine. Revista Brasileira de Farmacognosia 27:2, pages 228-235.
Crossref
Crossref
Roshan M. Borkar, Murali Mohan Bhandi, Ajay P. Dubey, V. Ganga Reddy, Prashanth Komirishetty, Prajwal P. Nandekar, Abhay T. Sangamwar, Ahmed Kamal, Sanjay K. Banerjee & R. Srinivas. (2016) An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug–drug and drug–herb interaction by LC‐ESI/MS/MS. Biomedical Chromatography 30:10, pages 1556-1572.
Crossref
Crossref
Sheila Annie Peters, Christopher R. Jones, Anna-Lena Ungell & Oliver J. D. Hatley. (2016) Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models. Clinical Pharmacokinetics 55:6, pages 673-696.
Crossref
Crossref
Erik Sjögren, Bertil Abrahamsson, Patrick Augustijns, Dieter Becker, Michael B. Bolger, Marcus Brewster, Joachim Brouwers, Talia Flanagan, Matthew Harwood, Christian Heinen, René Holm, Hans-Paul Juretschke, Marlies Kubbinga, Anders Lindahl, Viera Lukacova, Uwe Münster, Sibylle Neuhoff, Mai Anh Nguyen, Achiel van Peer, Christos Reppas, Amin Rostami Hodjegan, Christer Tannergren, Werner Weitschies, Clive Wilson, Patricia Zane, Hans Lennernäs & Peter Langguth. (2014) In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. European Journal of Pharmaceutical Sciences 57, pages 99-151.
Crossref
Crossref
Mahmud Kajbaf, Raffaella Ricci, Serenella Zambon & Stefano Fontana. (2012) Contribution of rat intestinal metabolism to the xenobiotics clearance. European Journal of Drug Metabolism and Pharmacokinetics 38:1, pages 33-41.
Crossref
Crossref
Artur Pałasz, Anna Wiaderkiewicz, Ryszard Wiaderkiewicz, Piotr Czekaj, Beata Czajkowska, Tomasz Lebda-Wyborny, Aneta Piwowarczyk & Aleksandra Bryzek. (2011) Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine. Genes & Nutrition 7:2, pages 197-207.
Crossref
Crossref
Wei Zhu & Eun Ju Jeong. 2011. Oral Bioavailability. Oral Bioavailability
461
473
.
Kevin J. Randall, John Turton & John R. Foster. (2011) Explant culture of gastrointestinal tissue: a review of methods and applications. Cell Biology and Toxicology 27:4, pages 267-284.
Crossref
Crossref
Kenji Ikemura, Kimihiko Urano, Hiroko Matsuda, Hideki Mizutani, Takuya Iwamoto & Masahiro Okuda. (2009) Decreased Oral Absorption of Cyclosporine A after Liver Ischemia-Reperfusion Injury in Rats: The Contribution of CYP3A and P-Glycoprotein to the First-Pass Metabolism in Intestinal Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics 328:1, pages 249-255.
Crossref
Crossref
Doreen Mitschke, Andreas Reichel, Gert Fricker & Ursula Moenning. (2008) Characterization of Cytochrome P450 Protein Expression along the Entire Length of the Intestine of Male and Female Rats. Drug Metabolism and Disposition 36:6, pages 1039-1045.
Crossref
Crossref
Hiroshi Komura & Masahiro Iwaki. (2008) Species Differences in In Vitro and In Vivo Small Intestinal Metabolism of CYP3A Substrates. Journal of Pharmaceutical Sciences 97:5, pages 1775-1800.
Crossref
Crossref
Sudhir N. Umathe, Pankaj V. Dixit, Vijendra kumar, Kuldeep U. Bansod & Manish M. Wanjari. (2008) Quercetin pretreatment increases the bioavailability of pioglitazone in rats: Involvement of CYP3A inhibition. Biochemical Pharmacology 75:8, pages 1670-1676.
Crossref
Crossref
Yukio Mori, Kenjiro Tatematsu, Akihiro Koide, Shigeyuki Sugie, Takuji Tanaka & Hideki Mori. (2006)
Modification by curcumin of mutagenic activation of carcinogenic
N
‐nitrosamines by extrahepatic cytochromes P‐450 2B1 and 2E1 in rats
. Cancer Science 97:9, pages 896-904.
Crossref
Crossref
Esther G. van de Kerkhof, Inge A. M. de Graaf, Marina H. de Jager, Dirk K. F. Meijer & Geny M. M. Groothuis. (2005) CHARACTERIZATION OF RAT SMALL INTESTINAL AND COLON PRECISION-CUT SLICES AS AN IN VITRO SYSTEM FOR DRUG METABOLISM AND INDUCTION STUDIES. Drug Metabolism and Disposition 33:11, pages 1613-1620.
Crossref
Crossref
C Arellano, C Philibert, O Lacombe, J Woodley & G Houin. (2004) Liquid chromatographic–mass spectrometric method to assess cytochrome P450-mediated metabolism of testosterone by rat everted gut sacs. Journal of Chromatography B 807:2, pages 263-270.
Crossref
Crossref